Wednesday, July 27, 2016 1:50:35 AM
PS: bold emphasis mine...
John Bonfiglio was named president and chief operating officer at TapImmune.
KATHLEEN CABBLE
A bioscience veteran in Tampa has been named president and chief operating officer of TapImmune Inc., a Jacksonville company developing a vaccine to treat cancer.
John Bonfiglio — formerly the president and CEO of Oragenics Inc. (OTC: OGEN) in Tampa — said his appointment will help TapImmune grow, potentially open a Tampa office, and strengthen the biotech industry throughout Florida.
Bonfiglio had been a strategic advisor to TapImmune (OTC: TPIV) since early 2015, working with Glynn Wilson, chairman and CEO.
“There was a need for more senior people to steer the company forward,” Bonfiglio said. “Glynn Wilson was doing everything for a while. I came on last February as a consultant, helping out, and together we made progress moving the company forward.”
Bonfiglio’s role as president and COO will be to run operations, making sure TapImmune is meeting milestones and has the right resources for clinical studies. He will work with Wilson to bring in financing as needed and to represent the company in front of investors.
The appointment comes at a time when TapImmune has four Phase II clinical trials underway or about to get underway for TPIV 200, technology licensed from the Mayo Foundation that has potential uses in treating ovarian cancer and triple-negative breast cancer. The vaccine stimulates the body’s cellular immune systems to recognize and fight metastatic cancer.
“Immuno-oncology is just beginning to bloom in science, with new drugs coming onto the market based on the fact that we understand the immune system better than in the past,” Bonfiglio said.
One of the clinical trial sites is at Moffitt Cancer Center in Tampa and TapImmune is talking with Moffitt about a potential second trial.
For now, Bonfiglio will work out of Tampa, where he’s close to the airport and the company’s law firm, Shumaker Loop & Kendrick.
“The company is pretty virtual at this point, with operations in Boca Raton and Fort Lauderdale and the corporate office in Jacksonville,” he said.
Show Full Article
RELATED CONTENT
3 ways to grow the tech sector in Tampa Bay
Tampa biopharma back on track with stock exchange
Moffitt collaboration accelerates blood cancer research
USF patent helps epileptics, holds promise for cancer, Alzheimer's
HOME OF THE DAY
Spectacular Spanish Mediterranean Style waterfront Home in Symphony Isles! SPONSOR LISTING
Spectacular Spanish Mediterranean Style waterfront Home in Symphony Isles!
See All Homes of the Day
INDUSTRIES HEALTH CARE
TOPICS BIOTECH PUBLIC COMPANIES
SUGGESTED READING
RESIDENTIAL REAL ESTATE
Tampa beer mogul buys waterfront home for $6.4 million
The bad things that happen when a start-up grows too fast (Video)
HEALTH CARE
Here's why Mel Sembler hates marijuana enough to spend $1 million to fight it
by Taboola
Sponsored Links
The Shift to Mobile: Only Built-In Security Will Overcome Human Weakness
The Wall Street Journal for PwC
5 Companies That May Not Survive This Year
The Fiscal Times
HEALTH CARE
‘Deficiencies’ at Bausch + Lomb manufacturing plant in Tampa put glaucoma drug on hold
HEALTH CARE
Tampa biopharma back on track with New York Stock Exchange
by Taboola
PEOPLE ON THE MOVE
James Holloman
James Holloman
Rotary Club of Central Pinellas
Robert Blank
Robert Blank
Rumberger, Kirk & Caldwell
Tyler Cathey
Tyler Cathey
Franklin Street
Dave Ford
Dave Ford
Hamilton Engineering & Surveying, Inc.
Duane Draper
Duane Draper
Bryant Miller Olive
Tiffany Accattato
Tiffany Accattato
Re/Max Bay to Bay
See All People on the Move
TRAVEL INDUSTRY
Southwest suffers massive tech headaches, affecting Tampa flights
EDUCATION
CEO says this is the one thing that keeps many people from big success (Video)
RETAILING AND RESTAURANTS
Tampa restaurant closed second time in two months for roaches
by Taboola
Sponsored Links
A Man Posted A Pic Of His Newborn's Bath Online. One Commenter Pointed Out Something Unbelievable
Answers
What Talia Shire Looks Like Today is Jaw-Dropping
InstyleBuzz
TECHNOLOGY
Tech firm brings 60 jobs to Tampa
RETAILING AND RESTAURANTS
Irish 31 owner plans to 'conquer' Florida, looking for sites in Orlando, Jacksonville (Video)
by Taboola
Recent MRKR News
- Korro Announces Addition of Industry Veteran Katharine Knobil to and Resignation of David Lucchino From Its Board of Directors • GlobeNewswire Inc. • 08/28/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 08:47:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 08:39:13 PM
- Marker Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 08/14/2024 08:30:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/12/2024 11:12:59 AM
- Marker Therapeutics Awarded $2 Million Grant from NIH in Support of Phase 1 Study Investigating MT-601 in CAR-Relapsed Patients with Non-Hodgkin’s Lymphoma • GlobeNewswire Inc. • 08/12/2024 11:00:57 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/12/2024 08:05:47 PM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 05/17/2024 10:25:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 08:40:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 08:03:21 PM
- Principal Investigator from City of Hope National Medical Center Invited to Present Clinical Data from Marker Therapeutics APOLLO Study at 11th Global Summit on Hematologic Malignancies • GlobeNewswire Inc. • 04/08/2024 11:00:39 AM
- Marker Therapeutics Reports Year-End 2023 Corporate and Financial Results • GlobeNewswire Inc. • 03/25/2024 09:45:00 PM
- Marker Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference • GlobeNewswire Inc. • 03/22/2024 04:30:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/01/2024 01:02:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 12:58:51 PM
- Marker Therapeutics Receives Approval from United States Adopted Name (USAN) Council and International Nonproprietary Names (INN) Expert Committee for “Neldaleucel” as Nonproprietary Name for MT-601 • GlobeNewswire Inc. • 01/22/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 01:30:48 PM
- Marker Therapeutics Announces Clinical Program Updates and Pipeline Prioritization • GlobeNewswire Inc. • 01/08/2024 01:24:49 PM
- Marker Therapeutics Announces Participation in Biotech Showcase and the 19th Annual Non-Dilutive Funding Summit During “J.P. Morgan Week 2024” • GlobeNewswire Inc. • 12/21/2023 04:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2023 12:35:22 PM
- Marker Therapeutics Announces Sustained Complete Response in First Lymphoma Patient Treated with MT-601 following CAR T Relapse • GlobeNewswire Inc. • 12/11/2023 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2023 09:37:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 10:03:53 PM
- Marker Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates • GlobeNewswire Inc. • 11/09/2023 10:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:31:53 PM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM